Literature DB >> 15184497

Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Patrick M Schlievert1, Timothy J Tripp, Marnie L Peterson.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15184497      PMCID: PMC427823          DOI: 10.1128/JCM.42.6.2875-2876.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Reporting of toxic shock syndrome Staphylococcus aureus in 1982 to 1990.

Authors:  P M Schlievert; M H Kim
Journal:  J Infect Dis       Date:  1991-12       Impact factor: 5.226

3.  Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS.

Authors:  P M Schlievert
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

4.  A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS.

Authors:  L A Cone; D R Woodard; R G Byrd; K Schulz; S M Kopp; P M Schlievert
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

5.  Nonmenstrual toxic shock syndrome: a review of 130 cases.

Authors:  A L Reingold; N T Hargrett; B B Dan; K N Shands; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

6.  Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness.

Authors:  K L MacDonald; M T Osterholm; C W Hedberg; C G Schrock; G F Peterson; J M Jentzen; S A Leonard; P M Schlievert
Journal:  JAMA       Date:  1987-02-27       Impact factor: 56.272

7.  Active surveillance for toxic shock syndrome in the United States, 1986.

Authors:  S Gaventa; A L Reingold; A W Hightower; C V Broome; B Schwartz; C Hoppe; J Harwell; L K Lefkowitz; S Makintubee; D R Cundiff
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

8.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

9.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

  9 in total
  32 in total

1.  A fatal case of staphylococcal toxic shock syndrome.

Authors:  Partha Roy; A K Sahni; Anshu Kumar
Journal:  Med J Armed Forces India       Date:  2013-08-02

2.  Staphylococcus aureus exotoxins are present in vivo in tampons.

Authors:  Patrick M Schlievert; Kimberly A Nemeth; Catherine C Davis; Marnie L Peterson; Bruce E Jones
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

3.  Reemergence of staphylococcal toxic shock syndrome in the United States since 2000.

Authors:  Philip M Tierno
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Staphylococcal superantigens cause lethal pulmonary disease in rabbits.

Authors:  Kristi L Strandberg; Jessica H Rotschafer; Sara M Vetter; Rebecca A Buonpane; David M Kranz; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

5.  Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005.

Authors:  Patrick M Schlievert; Laura C Case; Kristi L Strandberg; Timothy J Tripp; Ying-Chi Lin; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

6.  Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.

Authors:  Patrick M Schlievert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

7.  Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium.

Authors:  Huanli Liu; Yuan Gao; Li-Rong Yu; Richard C Jones; Christopher A Elkins; Mark E Hart
Journal:  Appl Environ Microbiol       Date:  2011-10-07       Impact factor: 4.792

8.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

9.  Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Patrick M Schlievert
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

10.  Evaluation of surveillance methods for staphylococcal toxic shock syndrome.

Authors:  Lindsey Lesher; Aaron Devries; Richard Danila; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.